vs
Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
Bitcoin Depot Inc. is the larger business by last-quarter revenue ($162.5M vs $123.8M, roughly 1.3× NATURES SUNSHINE PRODUCTS INC). Bitcoin Depot Inc. runs the higher net margin — 3.4% vs 3.3%, a 0.1% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $2.5M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -4.9%).
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
BTM vs NATR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $162.5M | $123.8M |
| Net Profit | $5.5M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 7.3% | 4.3% |
| Net Margin | 3.4% | 3.3% |
| Revenue YoY | 20.1% | 4.7% |
| Net Profit YoY | 690.4% | 1379.4% |
| EPS (diluted) | $0.08 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $123.8M | ||
| Q3 25 | $162.5M | $128.3M | ||
| Q2 25 | $172.1M | $114.8M | ||
| Q1 25 | $164.2M | $113.2M | ||
| Q4 24 | — | $118.2M | ||
| Q3 24 | $135.3M | $114.6M | ||
| Q2 24 | $163.1M | $110.6M | ||
| Q1 24 | $138.5M | $111.0M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | $5.5M | $5.3M | ||
| Q2 25 | $6.1M | $5.3M | ||
| Q1 25 | $4.2M | $4.7M | ||
| Q4 24 | — | $-321.0K | ||
| Q3 24 | $-939.0K | $4.3M | ||
| Q2 24 | $-2.6M | $1.3M | ||
| Q1 24 | $-1.5M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | — | 4.3% | ||
| Q3 25 | 7.3% | 7.0% | ||
| Q2 25 | 9.2% | 3.7% | ||
| Q1 25 | 10.8% | 5.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | 4.1% | 4.6% | ||
| Q2 24 | 4.7% | 5.1% | ||
| Q1 24 | 0.5% | 4.2% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | 3.4% | 4.2% | ||
| Q2 25 | 3.5% | 4.6% | ||
| Q1 25 | 2.6% | 4.2% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | -0.7% | 3.8% | ||
| Q2 24 | -1.6% | 1.2% | ||
| Q1 24 | -1.1% | 2.1% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | $0.08 | $0.30 | ||
| Q2 25 | $0.16 | $0.28 | ||
| Q1 25 | $0.20 | $0.25 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.05 | $0.23 | ||
| Q2 24 | $-0.13 | $0.07 | ||
| Q1 24 | $-0.25 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $93.9M |
| Total DebtLower is stronger | $67.5M | — |
| Stockholders' EquityBook value | $21.0M | $161.6M |
| Total Assets | $125.3M | $261.1M |
| Debt / EquityLower = less leverage | 3.21× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.9M | ||
| Q3 25 | $59.3M | $95.6M | ||
| Q2 25 | $48.0M | $81.3M | ||
| Q1 25 | $35.0M | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | $32.2M | $78.7M | ||
| Q2 24 | $43.9M | $68.7M | ||
| Q1 24 | $42.2M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | $67.5M | — | ||
| Q2 25 | $66.5M | — | ||
| Q1 25 | $56.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $44.5M | — | ||
| Q2 24 | $41.2M | — | ||
| Q1 24 | $37.6M | $2.1M |
| Q4 25 | — | $161.6M | ||
| Q3 25 | $21.0M | $166.7M | ||
| Q2 25 | $4.7M | $163.7M | ||
| Q1 25 | $-4.6M | $167.1M | ||
| Q4 24 | — | $161.0M | ||
| Q3 24 | $-7.9M | $162.6M | ||
| Q2 24 | $4.4M | $156.4M | ||
| Q1 24 | $5.0M | $159.7M |
| Q4 25 | — | $261.1M | ||
| Q3 25 | $125.3M | $264.8M | ||
| Q2 25 | $109.1M | $254.9M | ||
| Q1 25 | $89.7M | $252.7M | ||
| Q4 24 | — | $240.9M | ||
| Q3 24 | $87.4M | $245.3M | ||
| Q2 24 | $97.5M | $235.8M | ||
| Q1 24 | $90.1M | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | 3.21× | — | ||
| Q2 25 | 14.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.27× | — | ||
| Q1 24 | 7.54× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $9.9M |
| Free Cash FlowOCF − Capex | $2.5M | $7.6M |
| FCF MarginFCF / Revenue | 1.6% | 6.1% |
| Capex IntensityCapex / Revenue | 2.5% | 1.9% |
| Cash ConversionOCF / Net Profit | 1.20× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $27.1M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $9.9M | ||
| Q3 25 | $6.6M | $18.5M | ||
| Q2 25 | $10.2M | $4.3M | ||
| Q1 25 | $16.3M | $2.6M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | $5.8M | $9.6M | ||
| Q2 24 | $10.1M | $1.3M | ||
| Q1 24 | $1.3M | $2.2M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | $2.5M | $16.8M | ||
| Q2 25 | $9.8M | $3.0M | ||
| Q1 25 | $15.9M | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | $-1.0M | $7.9M | ||
| Q2 24 | $7.6M | $-2.0M | ||
| Q1 24 | $789.0K | $-1.5M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | 1.6% | 13.1% | ||
| Q2 25 | 5.7% | 2.6% | ||
| Q1 25 | 9.7% | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | -0.8% | 6.9% | ||
| Q2 24 | 4.7% | -1.9% | ||
| Q1 24 | 0.6% | -1.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | 2.5% | 1.3% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.2% | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | 5.0% | 1.5% | ||
| Q2 24 | 1.5% | 3.0% | ||
| Q1 24 | 0.4% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | 1.20× | 3.46× | ||
| Q2 25 | 1.67× | 0.81× | ||
| Q1 25 | 3.88× | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTM
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
